{"id":2648,"date":"2021-12-27T06:00:33","date_gmt":"2021-12-27T12:00:33","guid":{"rendered":"https:\/\/www.molllawgroup.com\/blog\/?p=2648"},"modified":"2021-12-19T22:21:14","modified_gmt":"2021-12-20T04:21:14","slug":"updates-on-zantac-multidistrict-litigation","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/","title":{"rendered":"Updates on Zantac Multidistrict Litigation"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-2650\" src=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-300x200.jpg\" alt=\"heartburn-gface8ec1a_640-300x200\" width=\"300\" height=\"200\" \/>You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). It\u2019s important to be aware, however, that Zantac has been linked to cancer and discontinued. On October 8<sup>th<\/sup>, a federal judge presiding over the <a href=\"https:\/\/www.flsd.uscourts.gov\/zantac\" target=\"_blank\" rel=\"noopener\">Zantac multidistrict litigation<\/a> ruled that the brand manufacturers of Zantac \u2014 GlaxoSmithKline, Sanofi, Pfizer, and Boehringer Ingelheim \u2014\u00a0should face lawsuits by people formerly prescribed the drug. If you were harmed by Zantac, you should call the experienced Chicago product liability lawyers of Moll Law Group. Billions have been recovered in cases with which we\u2019ve been involved around the country.<\/p>\n<p>The court denied requests by manufacturers that it dismiss a class action related to the drug\u2019s marketing and severe health issues. Additionally, however, the court ruled to dismiss all generic manufacturer cases; only cases against brand manufacturers may continue.<\/p>\n<p><strong>Losses from Zantac Use<\/strong><\/p>\n<p>The Zantac multidistrict litigation was pursued by patients prescribed Zantac who developed cancer and sustained losses as a result. Lawsuits allege that the drug\u2019s active ingredient is an unstable molecule and that the Zantac drug label did not properly warn the public that a risk of cancer existed.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#more-2648\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). It\u2019s important to be aware, however, that Zantac has been linked to cancer and discontinued. On October 8th, a federal judge presiding over the Zantac multidistrict litigation ruled that the brand manufacturers of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2650,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2648","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-liability"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Updates on Zantac Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 27, 2021<\/title>\n<meta name=\"description\" content=\"You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). &#8212; December 27, 2021\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Updates on Zantac Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 27, 2021\" \/>\n<meta name=\"twitter:description\" content=\"You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). &#8212; December 27, 2021\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Updates on Zantac Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 27, 2021","description":"You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). &#8212; December 27, 2021","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/","twitter_card":"summary_large_image","twitter_title":"Updates on Zantac Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 27, 2021","twitter_description":"You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). &#8212; December 27, 2021","twitter_image":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Updates on Zantac Multidistrict Litigation","datePublished":"2021-12-27T12:00:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/"},"wordCount":573,"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg","articleSection":["Product Liability"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/","url":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/","name":"Updates on Zantac Multidistrict Litigation &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; December 27, 2021","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#primaryimage"},"image":{"@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg","datePublished":"2021-12-27T12:00:33+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"You may have used prescription strength Zantac, a heartburn drug, to treat and stop stomach ulcers and address gastroesophageal reflux disease (GERD). &#8212; December 27, 2021","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#primaryimage","url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg","contentUrl":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg","width":525,"height":350},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/updates-on-zantac-multidistrict-litigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Updates on Zantac Multidistrict Litigation"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"https:\/\/www.molllawgroup.com\/blog\/wp-content\/uploads\/2021\/12\/heartburn-gface8ec1a_640-e1639973763665.jpg","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/2648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=2648"}],"version-history":[{"count":2,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/2648\/revisions"}],"predecessor-version":[{"id":2651,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/2648\/revisions\/2651"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media\/2650"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=2648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=2648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=2648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}